ResearcherUniversity of FreiburgNo recent work listed

Angela M. Krebs

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5003879567. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Co-author DOI 10.1038/ncb3513 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Melanie Boerries · 1 shared paper, 2017 · strength 0.06
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513 ↗
Marc P. Stemmler · 1 shared paper, 2017 · strength 0.06
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513 ↗
Wilfried Reichardt · 1 shared paper, 2017 · strength 0.06
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513 ↗
Thomas Brabletz · 1 shared paper, 2017 · strength 0.06
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513 ↗
Christian P. Pilarsky · 1 shared paper, 2017 · strength 0.06
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.